China-based Tianyin Pharmaceutical has completed the manufacturing environmental assessment (EA) at its 250-ton Jiangchuan Macrolide Facility (JCM).
Subscribe to our email newsletter
The EA will assess plant operation, macrolide branded generics and active pharmaceutical ingredients (API) production.
The company should abide by regulatory guidelines in terms of surface and ground water environmental quality status, ambient air quality status, API production industrial ingredients recycling, disposal and management, exhaust emissions, waste water pre-treatment recycling and management, noise environmental impact and assessment.
The JCM project is said to have met the national industrial policy and environmental protection guidelines for clean production process using technologies.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.